ClinicalTrials.Veeva

Menu

A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Mayo Clinic logo

Mayo Clinic

Status and phase

Invitation-only
Phase 2

Conditions

Chronic Kidney Diseases
Healthy

Treatments

Diagnostic Test: Super-resolution ultrasound imaging
Drug: Definity

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05764642
R01DK129205 (U.S. NIH Grant/Contract)
22-006499

Details and patient eligibility

About

The purpose of this research is to study the efficacy of ultrasound microvessel imaging for evaluation of Chronic Kidney Disease. Definity is an ultrasound contrast agent currently approved by the FDA for use on the heart, liver, and urinary tract. This study will look at its effectiveness on the kidney.

Enrollment

186 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

- Healthy volunteers or Chronic Kidney Disease (CKD) patients with clinically indicated renal biopsy.

Exclusion criteria

  • Subjects lacking capacity to consent.
  • Vulnerable subjects such as prisoners; pregnant women; nursing mother.
  • Subjects with history of hypersensitivity allergic reactions to ultrasound contrast agents.
  • Patients with high-risk cardiac diseases.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

186 participants in 2 patient groups

Chronic Kidney Disease Group
Experimental group
Description:
Subjects with Chronic Kidney Disease (CKD) with clinically indicated renal biopsy will have microvessel images obtained by Super-Resolution Ultrasound Imaging (SRUI) using Definity ultrasound contrast agent.
Treatment:
Drug: Definity
Diagnostic Test: Super-resolution ultrasound imaging
Healthy Control Group
Active Comparator group
Description:
Healthy volunteers with normal eGFR will have microvessel images obtained by Super-Resolution Ultrasound Imaging (SRUI) using Definity ultrasound contrast agent.
Treatment:
Drug: Definity
Diagnostic Test: Super-resolution ultrasound imaging

Trial contacts and locations

2

Loading...

Central trial contact

Bobbie Ott

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems